BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 10679926)

  • 1. Embryonic vasculogenesis by endothelial precursor cells derived from lung mesenchyme.
    Akeson AL; Wetzel B; Thompson FY; Brooks SK; Paradis H; Gendron RL; Greenberg JM
    Dev Dyn; 2000 Jan; 217(1):11-23. PubMed ID: 10679926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro model for developmental progression from vasculogenesis to angiogenesis with a murine endothelial precursor cell line, MFLM-4.
    Akeson AL; Brooks SK; Thompson FY; Greenberg JM
    Microvasc Res; 2001 Jan; 61(1):75-86. PubMed ID: 11162198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue interactions mediate early events in pulmonary vasculogenesis.
    Gebb SA; Shannon JM
    Dev Dyn; 2000 Feb; 217(2):159-69. PubMed ID: 10706140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VEGF enhances pulmonary vasculogenesis and disrupts lung morphogenesis in vivo.
    Zeng X; Wert SE; Federici R; Peters KG; Whitsett JA
    Dev Dyn; 1998 Mar; 211(3):215-27. PubMed ID: 9520109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors.
    Yamashita J; Itoh H; Hirashima M; Ogawa M; Nishikawa S; Yurugi T; Naito M; Nakao K; Nishikawa S
    Nature; 2000 Nov; 408(6808):92-6. PubMed ID: 11081514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor (VEGF) and its effect on angiogenesis.
    Jośko J; Gwóźdź B; Jedrzejowska-Szypułka H; Hendryk S
    Med Sci Monit; 2000; 6(5):1047-52. PubMed ID: 11208453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
    Yano S; Herbst RS; Shinohara H; Knighton B; Bucana CD; Killion JJ; Wood J; Fidler IJ
    Clin Cancer Res; 2000 Mar; 6(3):957-65. PubMed ID: 10741721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VEGF spatially directs angiogenesis during metanephric development in vitro.
    Tufró A
    Dev Biol; 2000 Nov; 227(2):558-66. PubMed ID: 11071774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphatic versus blood vascular endothelial growth factors and receptors in humans.
    Partanen TA; Paavonen K
    Microsc Res Tech; 2001 Oct; 55(2):108-21. PubMed ID: 11596156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Segregation of the embryonic vascular and hemopoietic systems.
    Eichmann A; Corbel C; Le Douarin NM
    Biochem Cell Biol; 1998; 76(6):939-46. PubMed ID: 10392707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VEGFs, receptors and angiogenesis.
    Veikkola T; Alitalo K
    Semin Cancer Biol; 1999 Jun; 9(3):211-20. PubMed ID: 10343072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of angiogenesis via vascular endothelial growth factor receptors.
    Veikkola T; Karkkainen M; Claesson-Welsh L; Alitalo K
    Cancer Res; 2000 Jan; 60(2):203-12. PubMed ID: 10667560
    [No Abstract]   [Full Text] [Related]  

  • 13. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.
    Wood JM; Bold G; Buchdunger E; Cozens R; Ferrari S; Frei J; Hofmann F; Mestan J; Mett H; O'Reilly T; Persohn E; Rösel J; Schnell C; Stover D; Theuer A; Towbin H; Wenger F; Woods-Cook K; Menrad A; Siemeister G; Schirner M; Thierauch KH; Schneider MR; Drevs J; Martiny-Baron G; Totzke F
    Cancer Res; 2000 Apr; 60(8):2178-89. PubMed ID: 10786682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of the mouse retinal vasculature: angiogenesis versus vasculogenesis.
    Fruttiger M
    Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):522-7. PubMed ID: 11818400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth factor signaling pathways in vascular development.
    Tallquist MD; Soriano P; Klinghoffer RA
    Oncogene; 1999 Dec; 18(55):7917-32. PubMed ID: 10630644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlation of angiogenesis with expression of vascular endothelial growth factor and its receptors in lung carcinoma].
    Zhang G; Zhao M; Xu M; Yang Y; Wang M; Yang C
    Zhonghua Jie He He Hu Xi Za Zhi; 2002 Feb; 25(2):89-93. PubMed ID: 11953105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Endothelial cell precursors in the avian embryo].
    Eichmann A; Corbel C
    Pathol Biol (Paris); 1999 Apr; 47(4):307-13. PubMed ID: 10372398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor and the regulation of angiogenesis.
    Ferrara N
    Recent Prog Horm Res; 2000; 55():15-35; discussion 35-6. PubMed ID: 11036931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor isoforms display distinct activities in promoting tumor angiogenesis at different anatomic sites.
    Guo P; Xu L; Pan S; Brekken RA; Yang ST; Whitaker GB; Nagane M; Thorpe PE; Rosenbaum JS; Su Huang HJ; Cavenee WK; Cheng SY
    Cancer Res; 2001 Dec; 61(23):8569-77. PubMed ID: 11731444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro.
    Tille JC; Wood J; Mandriota SJ; Schnell C; Ferrari S; Mestan J; Zhu Z; Witte L; Pepper MS
    J Pharmacol Exp Ther; 2001 Dec; 299(3):1073-85. PubMed ID: 11714897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.